So far, there are no data about the efficacy of GHB in treating AWS in inpatients with LC. In this study, we report a case of AWS in a hospitalized alcoholdependent patient with decompensated LC, successfully treated with GHB at a dosage of 100 mg/kg administered 4 times a day.
Caputo F, Bernardi M, Zoli G. (2011). Efficacy and safety of gamma hydroxybutyrate (GHB) in treating alcohol withdrawal syndrome in an alcohol-dependent in-patient with decompensated liver cirrhosis: a case report. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 31, 140-141 [10.1097/JCP.0b013e318203b36f].
Efficacy and safety of gamma hydroxybutyrate (GHB) in treating alcohol withdrawal syndrome in an alcohol-dependent in-patient with decompensated liver cirrhosis: a case report.
BERNARDI, MAURO;
2011
Abstract
So far, there are no data about the efficacy of GHB in treating AWS in inpatients with LC. In this study, we report a case of AWS in a hospitalized alcoholdependent patient with decompensated LC, successfully treated with GHB at a dosage of 100 mg/kg administered 4 times a day.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
